How to Invest in Tilray Stock

By Keith Speights – Updated Oct 16, 2025 at 4:57 PM | Fact-checked by Parker Hicks

Key Points

Tilray is well placed to profit from expanding global cannabis legalization.
Investors must assess their risk tolerance due to Tilray's high stock volatility.
Research Tilray's financial health and market strategy before investing.

Investing in Tilray (TLRY -5.34%) stock in recent years hasn't been for the faint of heart. Shares of the global cannabis company have soared -- and they've sunk. Today, though, Tilray Brands is arguably among the companies best positioned to profit as cannabis is legalized in more places.

Let's explore how to invest in Tilray. You'll also learn factors to consider in deciding whether the marijuana stock is a good pick for your investment portfolio.

NASDAQ: TLRY

Tilray Brands

Today's Change

(-5.34%) $-0.07

Current Price

$1.24

Key Data Points

Market Cap

$1B

Day's Range

$1.21 - $1.28

52wk Range

$0.35 - $2.32

Volume

49M

Avg Vol

82M

Gross Margin

20.17%

Dividend Yield

N/A

Stock

A stock represents an ownership interest in a business. When a business wants to raise money, its board of directors determines the number of shares to issue.

How to buy Tilray stock

Investing in marijuana stocks such as Tilray is really no different from investing in any stock. Just follow these basic steps

Open your brokerage account: Log in to your brokerage account where you handle your investments.
Search for the stock: Enter the ticker or company name into the search bar to bring up the stock's trading page.
Decide how many shares to buy: Consider your investment goals and how much of your portfolio you want to allocate to this stock.
Select order type: Choose between a market order to buy at the current price or a limit order to specify the maximum price you're willing to pay.
Submit your order: Confirm the details and submit your buy order.
Review your purchase: Check your portfolio to ensure your order was filled as expected and adjust your investment strategy accordingly.

Pots of hemp and marijuana plants — Source: Getty Images

The Motley Fool recommends using market orders to ensure that trades are executed immediately.

Loading paragraph...

Is Tilray profitable?

Tilray is finally profitable in Q4 of 2025, touting $67.6 million in gross profit. However, the company is already generating positive adjusted earnings before interest, taxes, depreciation, and amortization (EBITDA) -- an important prerequisite for achieving profitability.

Person holding magnifying glass up to cannabis plant inside dispensary. — Image source: Getty Images.

Does Tilray pay a dividend?

Most cannabis stocks don't have dividend programs. Tilray is no exception. Investors probably shouldn't expect the company to initiate a dividend anytime soon.

Exchange-Traded Fund (ETF)

An exchange-traded fund, or ETF, allows investors to buy many stocks or bonds at once.

Loading paragraph...

Will Tilray stock split?

While several companies have recently conducted stock splits, Tilray isn't in the group. The company has never conducted a stock split in its history and has not announced any plans to do so.

Investing in Marijuana Stocks

The continued legalization of marijuana means growth for companies in this sector.

Investing in Marijuana ETFs

Exchange-traded funds can help you invest in multiple marijuana stocks.

7 Steps to Investing in Marijuana Stocks

With pot markets growing like a weed, here's how to get your investing dollars involved.

A Guide to Marijuana Legalization in the United States

Medical and recreational marijuana legalization keeps puffing along. Here's where we are.

The bottom line on Tilray

Tilray is a highly volatile stock that operates in a challenging industry. However, the company could have tremendous long-term growth prospects in the global cannabis market, and with its expansion into beverage alcohol.

FAQ

About the Author

Keith Speights is a contributing Motley Fool healthcare analyst covering publicly traded companies across pharmaceuticals, biotechnology, medical devices, technology, and marijuana. Prior to The Motley Fool, Keith was CEO of Constant Care Technology, a healthcare technology company; vice president of American HealthTech, a healthcare software company; and a director of operations for Blue Cross Blue Shield of Mississippi, a health insurer. He holds a B.S. in Industrial Engineering from Mississippi State University.

TMFFishBiz

Keith Speights has no position in any of the stocks mentioned. The Motley Fool recommends Tilray Brands. The Motley Fool has a disclosure policy.